Core-shell nanoparticles (CSNPs) with diverse chemical compositions have been attracting greater attention in recent years. However, it has been a challenge to develop CSNPs with different crystal structures due to the lattice mismatch of the nanocrystals. Here we report a rational design of core-shell heterostructure consisting of NaYF 4 :Yb,Tm upconversion nanoparticle (UCN) as the core and ZnO semiconductor as the shell for potential application in photodynamic therapy (PDT). The core-shell architecture (confirmed by TEM and STEM) enables for improving the loading efficiency of photosensitizer (ZnO) as the semiconductor is directly coated on the UCN core. Importantly, UCN acts as a transducer to sensitize ZnO and trigger the generation of cytotoxic reactive oxygen species (ROS) to induce cancer cell death. We also present a firefly luciferase (FLuc) reporter gene based molecular biosensor (ARE-FLuc) to measure the antioxidant signaling response activated in cells during the release of ROS in response to the exposure of CSNPs under 980 nm NIR light. The breast cancer cells (MDA-MB-231 and 4T1) exposed to CSNPs showed significant release of ROS as measured by aminophenyl fluorescein (APF) and ARE-FLuc luciferase assays, and ,45% cancer cell death as measured by MTT assay, when illuminated with 980 nm NIR light. C ore-shell nanoparticles (CSNPs) have been attracting greater attention in recent years for biomedical applications 1-3 , owing to their diverse chemical compositions in achieving novel multi-functionalities. Photodynamic therapy (PDT) is emerging as a new treatment option for cancer therapy. PDT utilizes photosensitizers whose electrons can be excited to high energy level upon light illumination 4,5 . These excited electrons sensitize the ambient oxygen molecules to reactive oxygen species (ROS), which can destroy protein, lipid and nucleic acid to induce cell death. There are three major limitations in traditional PDT which uses UVvisible light for illumination: (i) a limited treatment depth due to shallow penetration in tissue of the UV-visible light, (ii) nonspecific tissue damage by natural light exposure to photosensitizer, and (iii) photo-damage of normal tissues by harmful UV light.
C ore-shell nanoparticles (CSNPs) have been attracting greater attention in recent years for biomedical applications [1] [2] [3] , owing to their diverse chemical compositions in achieving novel multi-functionalities. Photodynamic therapy (PDT) is emerging as a new treatment option for cancer therapy. PDT utilizes photosensitizers whose electrons can be excited to high energy level upon light illumination 4, 5 . These excited electrons sensitize the ambient oxygen molecules to reactive oxygen species (ROS), which can destroy protein, lipid and nucleic acid to induce cell death. There are three major limitations in traditional PDT which uses UVvisible light for illumination: (i) a limited treatment depth due to shallow penetration in tissue of the UV-visible light, (ii) nonspecific tissue damage by natural light exposure to photosensitizer, and (iii) photo-damage of normal tissues by harmful UV light.
Up-conversion nanoparticles (UCNs) have been used in PDT, and showed promising applications over the traditional PDT [6] [7] [8] [9] . Due to the unique electronic configuration of the doped lanthanide ions, near infrared (NIR) light (976 , 980 nm) is used for the illumination of UCNs. Recently, an enhanced upconversion luminescence in Tm 31 -doped NaYF 4 UCNs was achieved by high excitation irradiance and high activator concentration 10 . After absorbing longer wavelength NIR light, UCNs emit short wavelength UV or visible light. By designing UCNs as a transducer for sensitizing the attached photosensitizer, the aforementioned limitations of traditional UV PDT could be circumvented, improving the penetration depth of NIR light to tissues without photo-damage.
Currently, there are four major methods used to combine UCNs with photosensitizers for PDT. The first method is based on encapsulating photosensitizers into mesoporous silica coated on UCNs 6, 7 . Besides, covalent conjugation 8, 11 , electrostatic interactions 9 and lipid micelles encapsulations 12 have also been used to anchor the photosensitizers to the UCNs for PDT. These methods involve several time-consuming steps, starting from synthesis to surface modification, and photosensitizer loading or attachment. In the case of mesoporous silica coating method, the major limitation is the aggregation of the synthesized NPs after calcinations in obtaining mesoporous silica structure, which hinders the circulation of the NPs in serum and blood. In other methods, such as physical adsorption and electrostatic attraction, the premature release of photosensitizers might occur before the NPs reach to the desired target site.
ZnO NPs have been reported as efficient photosensitizers [13] [14] [15] since ZnO can sensitize the ambient oxygen to produce ROS. Coincidently, bandgap of ZnO (3.3 eV) 16, 17 matches perfectly with the emission peaks (330 , 370 nm) of one the most efficient UCNs (composed of NaYF 4 :Yb,Tm). Here we report a new approach to the synthesis of NaYF 4 :Yb,Tm (UCN)@ZnO in a core-shell manner for PDT applications. Compared to other nanomaterials used for PDT, our UCN@ZnO CSNPs exhibit four major advantages. Firstly, when compared to the conventional UV-visible light sensitized PDT, the PDT with CSNPs could reach deeper tissues since 980 nm NIR light for triggering PDT falls perfectly in the biological optical window. Secondly, light source (UCN) and photosensitizer (ZnO) can be easily incorporated in the core-shell structure. Thirdly, photosensitizer-loading efficiency can be controlled by CSNPs synthesis, as the photosensitizer is directly coated on the UCN core. Finally, the coreshell architecture eases photosensitizer loading procedures without considering much about the hydrophilicity, carrying charge and functional groups. Therefore, this design largely reduces the fabrication cycle and greatly improves the photosensitizer loading efficiency. In this work, we have used citrate ligand exchange method to obtain water soluble UCN@ZnO CSNPs in order to evaluate the therapeutic effect by measuring the ROS generation under NIR light irradiation.
We have also constructed genetically encoded FLuc reporter gene-expressed under antioxidant response element (ARE) containing ARE promoters derived from NAD(P)H (nicotinamide adenine dinucleotide phosphate) quinone oxidoreductase 1 (NQO1) and glutathione S-transferase (GST) genes, which are capable of measuring the activated antioxidant response signaling in cells by monitoring ROS production. In general, the induction of ROS in cells by any means can activate cellular antioxidant responsive genes, such as NAD(P)H (nicotinamide adenine dinucleotide phosphate) quinone oxidoreductase 1 (Nqo1), Glutamate-cysteine ligase, catalytic (Gclc), Heme oxygenase-1 (HO-1), glutathione S-transferase (GST), DP-glucuronosyltransferase (UGT), and Multidrug resistance-associated proteins (Mrps), especially to ameliorate cells from adverse effects [18] [19] [20] . Hence, the activation of the above genes in cancer cells can be indirectly used for measuring the cells response to PDT. In this work, we have measured the release of ROS in MDA-MB-231 breast cancer cells after treating them with CSNPs and excitation with NIR light by ARE-Luciferase reporter system. The Renilla luciferase reporter gene expression under an ubiquitin promoter showing no response to antioxidant signaling was used to normalize the ARE signaling measured by firefly luciferase.
Results
Design of UCN@ZnO CSNPs. Fig. 1 depicts the design and synthetic strategy of UCN@ZnO CSNPs. To obtain CSNPs, UCNs were synthesized first and used as the core. Next, Zn(acac) 2 was used as Zn precursor for the crystalline ZnO shell growth on the UCN core. As ZnO and UCN are fabricated in a core-shell manner, ZnO can utilize the UV-light emitted from the UCN after being excited by NIR light (980 nm), and sensitize ROS generation from oxygen for PDT. As the NIR light penetration is much larger than UV-Vis light in biological tissues, ROS generated in cells containing CSNPs upon NIR irradiation can induce cell death. Therefore, the specificity of PDT will be largely enhanced without much adverse side effects. Meanwhile, the other emission peaks of NaYF 4 :Yb,Tm UCN (not matching with the wavelength of ZnO absorbance) can be used simultaneously for bioimaging.
Structural characterization of CSNPs. The size distribution of assynthesized UCN@ZnO CSNPs (after purification) was measured by a nano-zeta sizer based on dynamic light scattering (DLS) principle. The polydispersity index (PDI) of the synthesized CSNPs was in the range of 0.139 to 0.201, and was consistent with different batches of samples ( Supplementary Figs. S1, S2 ). This result suggested that the prepared CSNPs were uniform in size and monodispersed in cyclohexane, which primarily confirmed the homogeneity of the CSNPs. Figs. 2a, 2b show the XRD patterns of UCN core and CSNPs, respectively. The XRD pattern of CSNPs (Fig. 2b) can be assigned to two crystalline hexagonal phases of NaYF 4 (the host lattice of UCN core) and ZnO (shell).
From the above two analyses, it was still early to exclude the possibility of forming two different types of NPs in similar size and further draw a conclusion that the core-shell structure was formed. To gain more insights, a high-resolution transmission electron microscope (HRTEM) was used as a direct proof to confirm the core-shell structure of the as-synthesized NPs. From the HRTEM image (Fig. 2c) , the inter-planar distance on the periphery of core UCN was measured to be 0.28 nm, corresponding to the (100) crystal plane of hexagonal phase ZnO 21, 22 . This observation confirms that ZnO is coated on the core UCN, yielding CSNPs. Additionally, the energy dispersive X-ray analysis (EDX, Supplementary Fig. S3 ) carried out on the sample in Figure 1b showed the presence of Zn, O and Y elements in the CSNPs. To obtain a higher contrast TEM image, the NPs were also examined by scanning transmission electron microscope (STEM), whose contrast is directly related to the atomic number of the element. In the STEM image (Fig. 2d) , it can be clearly seen that a continuous shell with uniform thickness of around 2-3 nm is coated on the UCN core. The STEM elemental mapping (Fig. 2e) shows that both Zn and O elements are located only on the periphery of the CSNPs, while fluorine is present in the core. All these observations from HRTEM and STEM confirm that a 2-3 nm ZnO shell is coated successfully on the UCN core.
Luminescent properties of CSNPs. The emission spectra of CSNPs and core UCN are compared in Fig. 3a . It can be seen that the emission peaks of UCN at 330-370 nm are dramatically suppressed in CSNPs. Coincidently, this wavelength range matches perfectly with the absorbance wavelength of ZnO. Conversely, the emission spectrum derived from a simple physical mixing of individual NPs of UCN and ZnO is the reminiscent of the emission of pure UCN. This indicates that there is no energy transfer between UCN and ZnO when they are physically mixed in solution. This also confirms that the core-shell structure is formed in as-synthesized NPs because the energy transfer occurs between NPs that are in close proximity 23 . Hydrophilic Conversion of CSNPs. As the CSNPs were synthesized in organic solvent, the hydrophobic surface had to be modified with hydrophilic ligands in order to perform the PDT. The ligand exchange with anhydrous sodium citrate was employed for producing water-soluble CSNPs. The success of the hydrophilic conversion of the CSNPs was monitored by the Fourier transform infrared spectroscopy (FTIR) by comparing the chemical bonds on the CSNPs surface before and after the conversion (Fig. 3b) . The peak at 3000 cm 21 , corresponding to the vibration stretching of methyl group 24 in oleic acid, disappeared after the surface modification with citrate. Meanwhile, new peaks at around 1250 cm 21 corresponding to the hydroxyl group from citrate 25, 26 appeared, confirming the successful ligand exchange with citrate. Unlike the surface modification with silica coating, the citrate-modified CSNP solution in water was stable and remained clear and transparent.
PDT evaluation of CSNPs in solution. The PDT application potential of the hydrophilic CSNPs was evaluated by measuring the ROS induced by 980 nm irradiation. The amount of ROS was measured with a light-induced oxidation resistant dye, 39-(paminophenyl) fluorescein (APF). This dye remains nonfluorescent until it reacts with ROS such as hydroxyl radical, peroxynitrite anion, and hypochlorite anion [27] [28] [29] . Thus, the ROS amount is directly proportional to the fluorescence intensity of APF dye. First, CSNPs were dispersed in water. After adding APF into the CSNPs solution, it was excited with 980 nm irradiation for 1 h, and the fluorescence of APF was recorded at every 20 min interval. As shown in Fig. 3c , the APF fluorescence intensity of the citrate-modified CSNPs increased with the time of NIR light exposure, indicating the increased generation of ROS with time. In contrast, citrate modified CSNPs without NIR irradiation, and APF in water solution did not show much increase in APF fluorescence. These results confirm that the UCN@ZnO CSNPs can sensitize ROS generation efficiently with 980 nm irradiation, indicating the PDT application potential of the CSNPs with NIR light.
Cytotoxicity of CSNPs. The toxicity of the CSNPs without NIR irridiation to cells was evaluated on both 4T1 and MDA-MB-231 cell lines. After incubating with 10, 25 and 50 mg/mL CSNPs, the viability of cells was recorded at three different time points (16, 28 and 48 h). The results showed that there was no significant impact on cell growth when the cells were incubated with low concentration (10 mg/mL) of CSNPs. Both the cell lines showed great compatibility up to 25 mg/mL CSNPs (Figs. 4a, 4b ), but MDA-MB-231 cells showed rising toxicity when incubated with CSNPs for longer time (28 h in Fig. 4b ). Both cell lines showed signficant reduction in cell viablity when cells were incubated with 50 mg/mL CSNPs. Both cell lines exhibited no cell death with 10 mg/mL CSNPs even after longer incubation time, indicating a safe concentration range of CSNPs that can be used for PDT with 980 nm NIR light irradiation. Hence, the particle concentration of 10 mg/mL was chosen for further light activations studies in this work.
Basal ROS level measurement by ARE-Luciferase assay. In general, there will be a basal level of ROS produced in normal cells at all times due to aerobic respiration 30, 31 . This can affect the detection limit of ROS in CSNPs treated cells after activation by NIR irradiation. Hence, it is important to evaluate the basal level of ROS released in cells in order to assess the ROS induced by CSNPs. ARE-Luciferase reporter gene assay 32 was used to measure the basal level of ROS in Figs. S4a, S4c) . This indicated that the ARE-luciferase signal derived from NQO1 promoter is not suitable for measuring ROS release during the PDT treatment of CSNPs. In contrast, the ARE derived from GST1-promoter showed consistently low background signal even at high concentration of CSNPs (25 mg/mL) used for this study, in both 4T1 and MDA-MB-231 cells ( Supplementary Figs. S4b, S4d) . Hence, GST1-ARE-luciferase was used for further evaluation of PDT effect of CSNPs.
Simultaneous measurement of ROS release and PDT effect of CSNPs in-vitro. After the confirmation of little cytotoxicity of CSNPs and basal ROS level evaluation, the PDT effect of CSNPs in MDA-MB-231 breast cancer cells was studied upon 980 nm light (5 mW) irradiation at different times. Similarly, MDA-MB-231 cells treated with PBS and 980 nm NIR light exposure for the same period of time served as controls. Cell death is a complicated event, which is not just caused by ROS release. Therefore, instead of only using the post-treatment cell viability to evaluate the PDT efficiency, ROS release was simultaneously assessed by ARE-Luciferase assay. The MDA-MB-231 cells were transfected with GST1-Luciferase and subsequently incubated with 10 mg/mL of CSNPs. The transfected cells were exposed to 980 nm NIR light irradiation for different times (0, 5, 10 and 30 min). Then, the luciferase activity was performed in order to determine antioxidant signaling induced by ROS. Subsequently, the cell viability after NIR treatment was evaluated by MTT assay after 24, 48 and 72 h of incubation at 37uC, 5% CO 2 in humidified atmosphere. The assay results (Fig. 6a) of control samples showed that the NIR light plays a rather minimal deleterious role in the breast cancer cells without the addition of CSNPs. In contrast, ,55% of cells remained alive for cells treated with 10 mg/mL CSNPs at 30 min NIR irradiation and 72 h postirradiation incubation (Fig. 6a) . Figs. 6b, 6c show that 10 mg/mL of CSNPs without NIR irradiation did not affect cell viability and ARE-luciferase activity over time. Within 48 h post-irradiation incubation, there was a significant increase in luciferase activity, indicating increase of ROS release; cell viability dropped with respect to the irradiation time. It is interesting to note that although luciferase activity reached to a maximum at 48 h post-irradiation incubation time (Fig. 6b) , the cells showed a maximum cell death at 72 h (Fig. 6c) . This can be ascribed to the fact that the cells stopped further expression of ARE-luciferase protein due to cell death, and the initiation of apoptosis in cells can lead to cell death 33, 34 . Thus, the remarkable reduction in the ARE-luciferase signal was observed in sample incubated for 72 h (Fig. 6b) . The PDT effect (cancer cell killing efficiency of 45%) is clearly evident for CSNPs at the concentration of 10 mg/mL with 30 min NIR irradiation and 72 h post-irradiation incubation.
Conclusion
We have developed a facile synthetic strategy for the fabrication of novel UCN@ZnO CSNPs for PDT. This design utilizes the emission of UCN for the sensitization of ROS generation with the aid of ZnO as photosensitizer, obviating the complicated procedures for the loading of photosensitizers. The unique core-shell combination of UCN and ZnO could be used for therapeutic application of deepseated tumors. We have also shown the use of GST-Luciferase assay to measure ROS by monitoring antioxidant signaling of the cells, and MTT assay for in-vitro PDT effect on MDA-MB-231 breast cancer cells. The results of MTT assay showed that ,45-50% cell death (IC 50 ) can be achieved for CSNPs at the concentration of 10 mg/ mL with 30 min NIR irradiation and 72 h post-irradiation incubation, which may provide some indications in deciding the dosage concentrations required for in vivo PDT evaluation.
Methods
Synthesis of UCN@ZnO CSNPs. The CSNPs were synthesized in two steps including a UCN core (composed of NaYF 4 :Yb,Tm) synthesis and a ZnO shell formation. First, UCN was synthesized according to the literature methods 35, 36 : YCl 3 (0.8 mmol), YbCl 3 (0.2 mmol), and TmCl 3 (0.003 mmol) were mixed with 6 mL oleic acid and 15 ml octadecene (ODE) in a 100 mL flask. The solution was heated to 160uC to form a homogeneous solution, and then cooled to room temperature. A 10 ml methanol solution containing NaOH (2.5 mmol) and NH 4 F (4 mmol) was slowly added into the flask and stirred for 30 min. The solution was slowly heated to remove methanol, degassed at 100uC for 10 min, and then heated to 300uC and maintained for 1 h under Argon protection. After the solution was cooled naturally, nanocrystals were precipitated from the solution with ethanol and washed with ethanol/water (151 v/v) three times. Second, ZnO shell growth was carried out with the as-synthesized UCNs. Typically, 0.5 mmol of Zn(acac) 2 and 1 mmol of 1,2-hexadecanediol were dissolved in 20 ml of diphenyl ether. 10 ml oleic acid and 100 ml oleylamine mixed with 0.05 mmol NaYF 4 :Yb,Tm in cyclohexane were then added into the solution and heated up to 100uC for 30 min. The temperature was gradually raised up to 160uC for 30 min and finally to 220uC for 1 h. After cooling to room temperature, the CSNPs were washed with acetone three times and collected by centrifugation at 8000 rpm.
Water-soluble CSNPs via citrate ligand exchange. Sodium citrate at a concentration of 2 mmol was dissolved in 15 ml diethylene glycol. Fifty milligram of the CSNPs obtained from the previous step dispersed in 5 ml cyclohexane and 2 ml chloroform, was added into the sodium citrate solution and heated at 160uC for 3 h. After the solution was cooled down to room temperature, the CSNPs were treated with 0.1 M HCl solution and washed with acetone and water three times. The CSNPs were finally dispersed in water for further characterization and in vitro studies.
Characterization of the CSNPs. TEM images were primarily obtained with a Philips EM300 electron microscope operated at an accelerating voltage of 300 kV. Elemental analysis was acquired with an energy-dispersive X-ray (EDX) equipped with the TEM. Scanning TEM (STEM) image was captured with an FEI Titan TEM with Schottky emitter operated at 200 kV. X-ray diffraction (XRD) patterns were collected by using a Bruker GADDS D8 Discover diffractometer with Cu Ka radiation (l 5 1.5418 Å ). Fluorescence spectra were acquired with a SpectraPro 2150i fluorescence spectrometer equipped with a commercial 980 nm NIR laser. Roomtemperature UV-visible absorption spectra were recorded with a Shimadzu UV-3150 UV/Vis spectrophotometer. Nano-zeta sizer measurements were performed on a Malvern zetasizer nano series.
Reactive oxygen species (ROS) measurement. To 1 mg of citrated modified UCN@ ZnO NPs dispersed in 1 mL ultra-pure water, 4 mL of 5 mM 39-(p-aminophenyl) fluorescein (APF, from Invitrogen) was added and mixed in a vortex to introduce enough oxygen into the solution. After irradiation with 1.08 W 980 nm laser, 100 mL solution was centrifuged at 12000 rpm for 5 min. The supernatant (50 mL) was transferred into a 96-well black plate (Costar) to check the ROS by APF fluorescence evaluation. The fluorescence intensity of the APF dye was measured at 520 nm with 485 nm excitation using Fluostar Optima for different periods of time (0, 20, 40, and 60 min) upon continuous irradiation. www.nature.com/scientificreports express under an ubiquitin promoter was co-transfected to normalize ARE-luciferase signal. We tested two different types of ARE-Luciferases (GST-Luciferase and NQO1-Luciferase) to best predict the downstream target gene of antioxidant signaling pathway for quick response to CSNPs induced ROS. In brief, to transfect 24-well plate the plasmids of GST-Luciferase or NQO1-Luciferase of 6.0 mg with 12 ng of Renilla Luciferase (R-Luc, for transfection normalization) were mixed with lipofectamine 2000 in 153 ratio in a serum free OptiMEM medium for complex formation. After 20 min, 50 mL (250 ng/well) of complex were added to each well. We changed the cells with a fresh medium after 24 h following transfection, and added CSNPs of required concentrations. After 30 min addition of CSNPs, the cells were exposed to 5 mW 980 nm NIR light to test CSNPs induced ROS release and its activation of ARE-Luciferase activity. Hotstuff 3 V 980 nm 5 mW Adjustable Focusable Infrared Laser Diode was used for cell studies.
Luciferase assays. The 4T1 and MDA-MB-231 cells co-transfected with NQO1/GST-ARE-Luciferase and Renilla luciferase expressed under a constitutive ubiquitin promoter were used as luciferase assays after the completion of specific experimental conditions as in the following. The cells were lysed by adding 100 mL of 13-passive lysis buffer (Promega, WI) by shaking for 15 min in a shaker. During this period, 1.2 mL of Luciferase Assay Reagent II (LAR II) was transferred into ice. The cell lysates transferred into 1.5 mL Eppendorf tubes were centrifuged at 10,000 g for 5 min at 25uC. After centrifugation, 20 mL of the supernatant from each tube were transferred into two fresh 1.5 mL micro-centrifuge tubes, one each for measuring Renilla and FLuc activities. Firefly and Renilla luciferase activities were measured by adding 100 mL of respective substrates (LARII for FLuc and Coelenterazine for Renilla luciferase) and measuring for 10 s in a Luminometer (Turner T20/20, Sunnyvale, CA). During this process, we also added 10 mL of supernatant from each sample into a 96-well plate, and measured protein concentration by using Bio-Rad protein assay reagent.
MTT assay. Although the transfection experimentation for luciferase assay provides information on the amount of ROS released by the cells in response to CSNPs at various treatment conditions, it does not provide any information on cell death. Therefore, we performed MTT assay to measure cell proliferation/viability after various treatment conditions with CSNPs. The cells plated in 24 well plates after different treatment conditions for various time points were exposed to 200 mL of 5 mg/mL solution of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (Sigma, St Louis) prepared in a phenol red free complete medium, and incubated further for 3 h at 37uC with 5% CO 2 . After incubation, the medium was aspirated carefully without disturbing newly formed precipitates, and 100 mL of dimethyl sulfoxide (DMSO) was added to each well. The plate was wrapped with aluminum foil and kept in the incubator for 15 min. The solutions in each well were transferred to separate 1.5 micro-centrifuge tubes, and centrifuged at 10,000 g for 5 min. Finally, 100 mL of solution was transferred into separate wells in a 96-well plate, and absorbance values were measured at 540 nm in a spectrophotometer.
